Evidence for action: a One Health learning platform on interventions to tackle antimicrobial resistance.


Journal

The Lancet. Infectious diseases
ISSN: 1474-4457
Titre abrégé: Lancet Infect Dis
Pays: United States
ID NLM: 101130150

Informations de publication

Date de publication:
12 2020
Historique:
received: 27 11 2019
revised: 20 04 2020
accepted: 23 04 2020
pubmed: 28 8 2020
medline: 7 1 2021
entrez: 28 8 2020
Statut: ppublish

Résumé

Improving evidence for action is crucial to tackle antimicrobial resistance. The number of interventions for antimicrobial resistance is increasing but current research has major limitations in terms of efforts, methods, scope, quality, and reporting. Moving the agenda forwards requires an improved understanding of the diversity of interventions, their feasibility and cost-benefit, the implementation factors that shape and underpin their effectiveness, and the ways in which individual interventions might interact synergistically or antagonistically to influence actions against antimicrobial resistance in different contexts. Within the efforts to strengthen the global governance of antimicrobial resistance, we advocate for the creation of an international One Health platform for online learning. The platform will synthesise the evidence for actions on antimicrobial resistance into a fully accessible database; generate new scientific insights into the design, implementation, evaluation, and reporting of the broad range of interventions relevant to addressing antimicrobial resistance; and ultimately contribute to the goal of building societal resilience to this central challenge of the 21st century.

Identifiants

pubmed: 32853549
pii: S1473-3099(20)30392-3
doi: 10.1016/S1473-3099(20)30392-3
pmc: PMC7444982
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e307-e311

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : CIHR
Pays : Canada

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

Lancet Infect Dis. 2015 Feb;15(2):212-24
pubmed: 25467650
Lancet. 2016 Jan 16;387(10015):285-95
pubmed: 26603921
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
BMC Health Serv Res. 2019 Oct 12;19(1):689
pubmed: 31606053
Nat Microbiol. 2019 Sep;4(9):1432-1442
pubmed: 31439928
Am J Infect Control. 2014 Oct;42(10 Suppl):S257-63
pubmed: 25239719
Implement Sci. 2007 Nov 30;2:40
pubmed: 18053122
Lancet Infect Dis. 2019 Nov;19(11):e371-e384
pubmed: 31588040
BMJ. 2017 Mar 6;356:i6795
pubmed: 28264797
Clin Microbiol Infect. 2019 Oct;25(10):1213-1225
pubmed: 31284031
BMC Med Res Methodol. 2017 Apr 26;17(1):76
pubmed: 28446138
J Antimicrob Chemother. 2018 Jun 1;73(6):1464-1478
pubmed: 29554263
Glob Health Action. 2018;11(1):1483637
pubmed: 29921172
J Antimicrob Chemother. 2020 May 1;75(5):1091-1098
pubmed: 31943008
PLoS Med. 2017 Aug 17;14(8):e1002378
pubmed: 28817562
Nature. 2016 Sep 07;537(7619):159-61
pubmed: 27604934
Implement Sci. 2016 Jul 08;11(1):91
pubmed: 27391959
Lancet Planet Health. 2017 Nov;1(8):e316-e327
pubmed: 29387833
J Antimicrob Chemother. 2019 Nov 1;74(11):3362-3370
pubmed: 31430366
BMJ Glob Health. 2019 Jan 25;4(Suppl 1):e000840
pubmed: 30775011
Bull World Health Organ. 2018 Apr 01;96(4):266-280
pubmed: 29695883
Clin Microbiol Infect. 2019 May;25(5):555-561
pubmed: 30472426
BMJ Open. 2018 Jan 21;8(1):e017832
pubmed: 29358424
BMJ Glob Health. 2019 Jan 25;4(Suppl 1):e000963
pubmed: 30775018
BMJ. 2004 Jun 19;328(7454):1490
pubmed: 15205295
Nature. 2014 May 29;509(7502):555-7
pubmed: 24877180
Lancet Planet Health. 2018 Sep;2(9):e398-e405
pubmed: 30177008
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
BMC Res Notes. 2018 Mar 12;11(1):170
pubmed: 29530079
N Engl J Med. 2017 Aug 3;377(5):465-475
pubmed: 28767357
Cochrane Database Syst Rev. 2017 Feb 09;2:CD003543
pubmed: 28178770
J Hosp Infect. 2017 Aug;96(4):316-322
pubmed: 28622980
J Epidemiol Community Health. 2002 Feb;56(2):119-27
pubmed: 11812811
Lancet. 2017 Dec 9;390(10112):2602-2604
pubmed: 28622953
PLoS Med. 2019 Jun 11;16(6):e1002819
pubmed: 31185011

Auteurs

Didier Wernli (D)

Geneva Transformative Governance Lab, Global Studies Institute, University of Geneva, Geneva, Switzerland; School of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address: didier.wernli@unige.ch.

Peter S Jørgensen (PS)

Global Economic Dynamics and the Biosphere, The Royal Swedish Academy of Sciences, Stockholm, Sweden; Stockholm Resilience Centre, Stockholm University, Stockholm, Sweden.

E Jane Parmley (EJ)

Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada.

Max Troell (M)

Beijer Institute of Ecological Economics, The Royal Swedish Academy of Sciences, Stockholm, Sweden; Stockholm Resilience Centre, Stockholm University, Stockholm, Sweden.

Shannon Majowicz (S)

School of Public Health and Health Systems, University of Waterloo, Waterloo, ON, Canada.

Stephan Harbarth (S)

Infection Control Program and World Health Organization Collaborating Centre on Patient Safety, University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Anaïs Léger (A)

Geneva Transformative Governance Lab, Global Studies Institute, University of Geneva, Geneva, Switzerland.

Irene Lambraki (I)

School of Public Health and Health Systems, University of Waterloo, Waterloo, ON, Canada.

Tiscar Graells (T)

Global Economic Dynamics and the Biosphere, The Royal Swedish Academy of Sciences, Stockholm, Sweden; Stockholm Resilience Centre, Stockholm University, Stockholm, Sweden.

Patrik J G Henriksson (PJG)

Beijer Institute of Ecological Economics, The Royal Swedish Academy of Sciences, Stockholm, Sweden; Stockholm Resilience Centre, Stockholm University, Stockholm, Sweden; WorldFish, Penang, Malaysia.

Carolee Carson (C)

Centre for Foodborne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada, Guelph, ON, Canada.

Melanie Cousins (M)

School of Public Health and Health Systems, University of Waterloo, Waterloo, ON, Canada.

Gunilla Skoog Ståhlgren (G)

Unit for Antibiotics and Infection Control, The Public Health Agency of Sweden, Solna, Sweden.

Chadag V Mohan (CV)

WorldFish, Penang, Malaysia.

Andrew J H Simpson (AJH)

Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine Research Building, University of Oxford, Oxford, UK; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos.

Barbara Wieland (B)

International Livestock Research Institute, Nairobi, Kenya.

Karl Pedersen (K)

National Veterinary Institute, Uppsala, Sweden.

Annegret Schneider (A)

Department of Clinical, Educational and Health Psychology, University College London, London, UK.

Sujith J Chandy (SJ)

Department of Pharmacology and Clinical Pharmacology, Christian Medical College, Vellore, India.

Tikiri Priyantha Wijayathilaka (TP)

World Organisation for Animal Health, OIE Sub-Regional Representation for South East Asia, Bangkok, Thailand.

Jérôme Delamare-Deboutteville (J)

WorldFish, Penang, Malaysia.

Jordi Vila (J)

Department of Clinical Microbiology, Biomedical Diagnostic Center, Hospital Clinic School of Medicine and Barcelona Institute for Global Health, University of Barcelona, Barcelona, Spain.

Cecilia Stålsby Lundborg (C)

Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.

Didier Pittet (D)

Infection Control Program and World Health Organization Collaborating Centre on Patient Safety, University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH